Jefferies maintains Quantinuum at Buy, lowers price target to $65 from $85

Jefferies kept its Buy rating on Quantinuum but reduced its price target to $65 from $85, citing a 23.5% decrease. The new target suggests a 73% upside from the Nov 6 close of $37.57. Analysts' recent price targets for Quantinuum range from $55 to $155.

Original reporting
Published Nov 7, 2026, 12:22 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 7, 2026, 12:26 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Jefferies maintains Quantinuum at Buy, lowers price target to $65 from $85 — source image
Decision brief

The 30-second read

Med
01

Why it matters

The downgrade signals a shift in expectations for Quantinuum's growth trajectory, potentially prompting sell‑side pressure.

02

Market read

A fresh analyst downgrade on a newly listed quantum‑tech stock can drive short‑term price movement and affect sector sentiment.

03

What to watch

Recent contract wins or technology milestones not mentioned could offset the downgrade.

Relevance 6/10Novelty 6/10Timing: pre-market today

Background

Quantinuum is a quantum‑computing firm recently listed on NASDAQ. Analyst coverage is limited, making price‑target changes notable.

Market effects

May affect other quantum‑computing peers as analysts reassess valuations.

Limited to US‑listed quantum technology stocks.

Low global impact beyond the niche sector.

Counterpoint

Some investors may view the cut as an overreaction and see upside potential.

Key entities

  • Jefferies

    Equity research firm that issued the price‑target cut.

  • Quantinuum

    Quantum‑computing company listed on NASDAQ under ticker QTM.

Related articles

$QNTMedAI 8/10

What Quantinuum (QNT) Said on Its Q3 Earnings Call

Quantinuum (QNT) reported Q3 R&D expenses of $97.5M, up from $42.4M a year earlier, with $1.9B in cash and no debt. CEO Raj Hazra confirmed progress on Sol and Apollo quantum systems, targeting commercial availability in 2027 and 2029, respectively. The company secured a $100M DoC CHIPS award and expanded cloud partnerships, including a multiyear deal with an unnamed financial institution.